CARCINOMA IN SITU

CARCINOMA IN SITU was reported 167 times

CARCINOMA IN SITU is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
1 Osmotic Diuretic [EPC] 1 0.0002
2 Sphingosine 1-phosphate Receptor Modulator [EPC] 2 0.0001
3 Vitamin D2 Analog [EPC] 1 0.0001
4 Purine Antimetabolite [EPC] 11 0.0001
5 Chloride Channel Activator [EPC] 1 0.0001
6 Sulfone [EPC] 1 0.0001
7 GLP-2 Analog [EPC] 1 0.0001
8 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
9 Vitamin D Analog [EPC] 1 0.0001
10 Aromatase Inhibitor [EPC] 6 0.0001
11 Selective T Cell Costimulation Modulator [EPC] 7 0.0001
12 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
13 Protease Inhibitor [EPC] 2 0.0000
14 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
15 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
16 Alkaloid [EPC] 1 0.0000
17 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
18 Microtubule Inhibitor [EPC] 6 0.0000
19 Nitrate Vasodilator [EPC] 3 0.0000
20 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
21 Alkylating Drug [EPC] 8 0.0000
22 Sympathomimetic-like Agent [EPC] 1 0.0000
23 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
24 Interleukin-6 Receptor Antagonist [EPC] 4 0.0000
25 alpha-Adrenergic Blocker [EPC] 4 0.0000
26 Progestin [EPC] 8 0.0000
27 Interleukin-17A Antagonist [EPC] 1 0.0000
28 Estrogen [EPC] 5 0.0000
29 Nucleoside Metabolic Inhibitor [EPC] 7 0.0000
30 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
31 Thiazide Diuretic [EPC] 5 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 9 0.0000
33 Thiazide-like Diuretic [EPC] 1 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 23 0.0000
35 General Anesthetic [EPC] 1 0.0000
36 Folate Analog Metabolic Inhibitor [EPC] 10 0.0000
37 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
38 Interferon beta [EPC] 4 0.0000
39 Aminosalicylate [EPC] 2 0.0000
40 beta-Adrenergic Blocker [EPC] 6 0.0000
41 Corticosteroid [EPC] 24 0.0000
42 Parathyroid Hormone Analog [EPC] 2 0.0000
43 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
44 Vitamin D [EPC] 5 0.0000
45 Sulfonylurea [EPC] 2 0.0000
46 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
47 Nitroimidazole Antimicrobial [EPC] 1 0.0000
48 Cardiac Glycoside [EPC] 1 0.0000
49 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
50 Kinase Inhibitor [EPC] 7 0.0000
51 Angiotensin 2 Receptor Blocker [EPC] 4 0.0000
52 Vitamin B12 [EPC] 4 0.0000
53 Vitamin C [EPC] 5 0.0000
54 Nonsteroidal Anti-inflammatory Drug [EPC] 15 0.0000
55 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
56 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
57 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
58 Acetylcholine Release Inhibitor [EPC] 1 0.0000
59 Interleukin-23 Antagonist [EPC] 1 0.0000
60 Antirheumatic Agent [EPC] 1 0.0000
61 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
62 Loop Diuretic [EPC] 4 0.0000
63 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
64 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
65 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
66 Opioid Agonist [EPC] 2 0.0000
67 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
68 Leukocyte Growth Factor [EPC] 1 0.0000
69 Proton Pump Inhibitor [EPC] 4 0.0000
70 GLP-1 Receptor Agonist [EPC] 3 0.0000
71 Azole Antifungal [EPC] 1 0.0000
72 Janus Kinase Inhibitor [EPC] 1 0.0000
73 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
74 Benzodiazepine [EPC] 4 0.0000
75 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
76 Platelet Aggregation Inhibitor [EPC] 2 0.0000
77 Insulin Analog [EPC] 1 0.0000
78 Atypical Antipsychotic [EPC] 1 0.0000
79 Thalidomide Analog [EPC] 1 0.0000